Study finds brain atrophy reduces in Lemtrada patients

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Study finds brain atrophy reduces in Lemtrada patients

Post by MSUK »

Genzyme has announced new magnetic resonance imaging (MRI) data from the Lemtrada clinical development program.

In relapsing remitting multiple sclerosis (RRMS) patients treated with Lemtrada in the Phase III pivotal studies, MRI effects observed in the two-year trials were maintained through two additional years in the extension study (years three and four). After the initial two courses of treatment in the pivotal studies, which were given at month zero and at month 12, approximately 70 percent of Lemtrada patients did not receive additional Lemtrada treatment during the following three years, through month 48............. Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Campath (Lemtrada, Alemtuzumab)”